Open-label crossover study for the efficasy of Escitalopram and Mecobalamin for patients with tinnitus.
Not Applicable
- Conditions
- tinnitus
- Registration Number
- JPRN-UMIN000013421
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1.allergy for Escitalopram 2.arrhythmia and QT prolongation 3.heart failure 4.hepatic disorder 5.mental disorder 6.epilepsy 7.lactating 8.others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of Tinnitus Handicap Inventory
- Secondary Outcome Measures
Name Time Method